Interestingly, a recent work by Flinner and colleagues [27] found by comparison with OncoScan data that the distinction between GS and CIN based on E-cadherin and p53 status and Lauren morphology can lead to mislabeling. This evidence concerns the gene TP53 and cervical squamous intraepithelial neoplasia.